Encomium
The United States’ National Institutes of Health (NIH) announced yesterday (August 28) that it will start human trials of an experimental Ebola vaccine by the middle of next month.
Drugs giant – GlaxoSmithKline – plan to stockpile 10,000 emergency doses of the drug if the trials are successful and will start using them for treatment in affected countries – including Mali and Gambia.
This is coming on the heels of the chilling revelations made by the World Health Organization (WHO) that the Ebola outbreak was accelerating and could affect 20,000 people.
